EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Anemia of Chronic Disease: Pathophysiology, Diagnosis and Management

Keziah Abbotts, Priya Sriskandarajah iD

Hematology Reports · 02.07.2026 · 18 (4) · 48

DOI: 10.3390/hematolrep18040048 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hematology Reports, online erschienen am 02.07.2026. Verfasst von Keziah Abbotts und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anemia of chronic disease (ACD) is a condition linked to chronic immune activation secondary to a wide range of infectious, inflammatory, and autoimmune diseases. It is characterized by a state of iron-restricted erythropoiesis, in which prolonged activation of cytokines leads to retention of iron within the reticulo-endothelial system, driven primarily by hepcidin. Reduced iron availability contributes to a blunted response by erythropoietin and impaired erythropoiesis, in addition to a shortened red cell lifespan. In patients found to have anemia and evidence of chronic inflammation, parameters such as mean cell volume, iron studies, percentage of hypochromic red cells, reticulocyte hemoglobin content, and levels of ferritin, serum transferrin receptor, hepcidin, erythropoietin, and GDF15 are all used to build a picture of anemia of chronic disease. Following this, management normally utilizes erythropoietin-stimulating agents alongside parenteral iron supplementation when treatment of the underlying cause is not available. Newer therapies, such as hypoxia-inducible factor prolyl hydroxylase inhibitors and hepcidin inhibitors, also play a role, while cytokine targets, carbon dots, androgens, and other therapies are emerging as possible treatment routes. Despite its high prevalence, there remain few standardized methods of diagnosis or management in anemia of chronic disease. This narrative review explores long-standing and emerging practices in the diagnosis and management of this condition to ensure an up-to-date understanding.

Schlagwörter

Stichwörter der Autor:innen

anemia of chronic diseasefunctional iron deficiencyinflammation

Autor:innen und Institutionen

  • Department of Haematology, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.

ORCID-Profile: Priya Sriskandarajah

Zitieren

APA

Abbotts, K., & Sriskandarajah, P. (2026). Anemia of Chronic Disease: Pathophysiology, Diagnosis and Management. Hematology Reports, 18(4), 48. https://doi.org/10.3390/hematolrep18040048

Vancouver

Abbotts K, Sriskandarajah P. Anemia of Chronic Disease: Pathophysiology, Diagnosis and Management. Hematology Reports. 2026;18(4):48. doi:10.3390/hematolrep18040048

BibTeX
@article{Abbotts2026,
  author = {Abbotts, Keziah and Sriskandarajah, Priya},
  title = {Anemia of Chronic Disease: Pathophysiology, Diagnosis and Management},
  journal = {Hematology Reports},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {48},
  doi = {10.3390/hematolrep18040048}
}
Kostenlos starten →